EDN2_HORSE
ID EDN2_HORSE Reviewed; 178 AA.
AC Q867D0;
DT 19-JUL-2004, integrated into UniProtKB/Swiss-Prot.
DT 01-JUN-2003, sequence version 1.
DT 03-AUG-2022, entry version 84.
DE RecName: Full=Endothelin-2;
DE Short=ET-2;
DE AltName: Full=Preproendothelin-2;
DE Short=PPET2;
DE Flags: Precursor;
GN Name=EDN2;
OS Equus caballus (Horse).
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC Eutheria; Laurasiatheria; Perissodactyla; Equidae; Equus.
OX NCBI_TaxID=9796;
RN [1]
RP NUCLEOTIDE SEQUENCE [MRNA].
RX PubMed=15838341; DOI=10.1097/01.fjc.0000166312.53506.06;
RA Uchide T., Fujimori Y., Temma K., Sasaki T., Kizaki K., Hara Y.,
RA Takizawa S., Saida K.;
RT "cDNA cloning, sequence analysis and organ distribution of horse
RT preproendothelin-2.";
RL J. Cardiovasc. Pharmacol. 44:S430-S434(2004).
CC -!- FUNCTION: Endothelins are endothelium-derived vasoconstrictor peptides.
CC -!- SUBCELLULAR LOCATION: Secreted.
CC -!- SIMILARITY: Belongs to the endothelin/sarafotoxin family.
CC {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; AB079136; BAC54893.1; -; mRNA.
DR RefSeq; NP_001075292.1; NM_001081823.2.
DR AlphaFoldDB; Q867D0; -.
DR STRING; 9796.ENSECAP00000042152; -.
DR PRIDE; Q867D0; -.
DR Ensembl; ENSECAT00000024760; ENSECAP00000020586; ENSECAG00000023173.
DR GeneID; 100033847; -.
DR KEGG; ecb:100033847; -.
DR CTD; 1907; -.
DR VGNC; VGNC:58625; EDN2.
DR GeneTree; ENSGT00950000183053; -.
DR InParanoid; Q867D0; -.
DR OrthoDB; 1264335at2759; -.
DR Proteomes; UP000002281; Chromosome 2.
DR Bgee; ENSECAG00000023173; Expressed in zone of skin and 6 other tissues.
DR GO; GO:0005615; C:extracellular space; IBA:GO_Central.
DR GO; GO:0031708; F:endothelin B receptor binding; IBA:GO_Central.
DR GO; GO:0005179; F:hormone activity; IBA:GO_Central.
DR GO; GO:0006874; P:cellular calcium ion homeostasis; IBA:GO_Central.
DR GO; GO:0060585; P:positive regulation of prostaglandin-endoperoxide synthase activity; IBA:GO_Central.
DR GO; GO:0003100; P:regulation of systemic arterial blood pressure by endothelin; IBA:GO_Central.
DR GO; GO:0019229; P:regulation of vasoconstriction; IEA:InterPro.
DR GO; GO:0014826; P:vein smooth muscle contraction; IBA:GO_Central.
DR InterPro; IPR020475; Endothelin.
DR InterPro; IPR019764; Endothelin_toxin_CS.
DR InterPro; IPR001928; Endothln-like_toxin.
DR InterPro; IPR015658; ET-2.
DR PANTHER; PTHR13874; PTHR13874; 1.
DR PANTHER; PTHR13874:SF9; PTHR13874:SF9; 1.
DR Pfam; PF00322; Endothelin; 1.
DR PRINTS; PR00365; ENDOTHELIN.
DR SMART; SM00272; END; 2.
DR PROSITE; PS00270; ENDOTHELIN; 2.
PE 2: Evidence at transcript level;
KW Cleavage on pair of basic residues; Disulfide bond; Reference proteome;
KW Secreted; Signal; Vasoactive; Vasoconstrictor.
FT SIGNAL 1..24
FT /evidence="ECO:0000255"
FT PROPEP 25..46
FT /evidence="ECO:0000250"
FT /id="PRO_0000008087"
FT PEPTIDE 49..69
FT /note="Endothelin-2"
FT /id="PRO_0000008088"
FT PROPEP 70..178
FT /evidence="ECO:0000250"
FT /id="PRO_0000008089"
FT REGION 25..45
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT REGION 96..111
FT /note="Endothelin-like"
FT SITE 69..70
FT /note="Cleavage; by KEL"
FT /evidence="ECO:0000250"
FT DISULFID 49..63
FT /evidence="ECO:0000250"
FT DISULFID 51..59
FT /evidence="ECO:0000250"
SQ SEQUENCE 178 AA; 19795 MW; 815C39BA0B891634 CRC64;
MVAMPPAWCS VALALLVALH EGEGQATATP EQPVPSPRAQ GSHLRPRRCS CSSWLDKECV
YFCHLDIIWV NTPGQTAPYG LGNPPRRRRR SLPRRCECSS ARDPACATFC HRRPWADAVA
VPGSDSPEDT FQAGKTWTTA GELLQQLRGI SAANIRFARR QQEAIRAPRP TPSRRRKR